Effects of Different Coffee Amounts on Energy Intake, Appetite, Glucose Metabolism and Inflammatory Markers
The Effect of Different Amounts of Coffee on Dietary Intake, Appetite-related Feeling, Appetite Hormones, Glucose Metabolism and Inflammatory Markers of Normal Weight and Overweight/Obese Individuals
1 other identifier
interventional
33
1 country
1
Brief Summary
The purpose of the study is to investigate whether different doses of caffeinated coffee consumption has acute effects on subjective appetite feelings, energy intake and biochemical markers related to appetite, inflammation and glucose metabolism compared to water consumption in normal weight and overweight/obese participants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable obesity
Started Jan 2011
Shorter than P25 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2011
CompletedFirst Submitted
Initial submission to the registry
December 16, 2011
CompletedFirst Posted
Study publicly available on registry
December 20, 2011
CompletedDecember 20, 2011
December 1, 2011
5 months
December 16, 2011
December 19, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (38)
energy intake ad libitum
180 min after breakfast/drink consumption
total energy intake
One day
appetite feelings
fasting (-15 min)
appetite feelings
immediately after breakfast/drink consumption (0 min)
appetite feelings
15 min after breakfast/drink consumption
appetite feelings
30 min after breakfast/drink consumption
appetite feelings
60 min after breakfast/drink consumption
appetite feelings
90 min after breakfast/drink consumption
appetite feelings
120 min after breakfast/drink consumption
appetite feelings
150 min after breakfast/drink consumption
appetite feelings
180 min after breakfast/drink consumption
appetite hormones
fasting (-15 min)
appetite hormones
immediately after breakfast/drink consumption (0 min)
appetite hormones
15 min after breakfast/drink consumption
appetite hormones
30 min after breakfast/drink consumption
appetite hormones
60 min after breakfast/drink consumption
appetite hormones
90 min after breakfast/drink consumption
appetite hormones
120 min after breakfast/drink consumption
appetite hormones
150 min after breakfast/drink consumption
appetite hormones
180 min after breakfast/drink consumption
markers of inflammation
fasting (-15 min)
markers of inflammation
immediately after breakfast/drink consumption (0 min)
markers of inflammation
15 min after breakfast/drink consumption
markers of inflammation
30 min after breakfast/drink consumption
markers of inflammation
60 min after breakfast/drink consumption
markers of inflammation
90 min after breakfast/drink consumption
markers of inflammation
120 min after breakfast/drink consumption
markers of inflammation
150 min after breakfast/drink consumption
markers of inflammation
180 min after breakfast/drink consumption
markers of glucose metabolism
fasting (-15 min)
markers of glucose metabolism
immediately after breakfast/drink consumption (0 min)
markers of glucose metabolism
15 min after breakfast/drink consumption
markers of glucose metabolism
30 min after breakfast/drink consumption
markers of glucose metabolism
60 min after breakfast/drink consumption
markers of glucose metabolism
90 min after breakfast/drink consumption
markers of glucose metabolism
120 min after breakfast/drink consumption
markers of glucose metabolism
150 min after breakfast/drink consumption
markers of glucose metabolism
180 min after breakfast/drink consumption
Secondary Outcomes (6)
% carbohydrates ad libitum
180 min after breakfast/drink consumption
% carbohydrates total day
One day
% protein ad libitum
180 min after breakfast/drink consumption
% protein total day
One day
% fat
180 min after breakfast/drink consumption
- +1 more secondary outcomes
Study Arms (3)
coffee3
EXPERIMENTALcoffee6
EXPERIMENTALwater
PLACEBO COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- apparently healthy
- habitual coffee drinkers (\>= 1cup of coffee/day)
You may not qualify if:
- smokers
- restrained eaters (as this was evaluated using the Dutch Eating Behaviour Questionnaire)
- those who reported slimming or any other dietary regime
- athletes
- participants with a known diagnosis of either hypertension, diabetes, impaired glucose tolerance or a fasting blood glucose concentration above 125 mg/dl
- subjects on medication for hypertension or on medication known to alter glucose metabolism
- subjects who were on medication that may have an impact on appetite and sensory functioning or who reported a metabolic or
- endocrine disease,
- gastrointestinal disorders,
- a history of medical or surgical events that may have affected the study outcomes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Metabolic Unit of the Department of Nutrition and Dietetics, Harokopio University
Athens, 17671, Greece
Related Publications (3)
Gavrieli A, Yannakoulia M, Fragopoulou E, Margaritopoulos D, Chamberland JP, Kaisari P, Kavouras SA, Mantzoros CS. Caffeinated coffee does not acutely affect energy intake, appetite, or inflammation but prevents serum cortisol concentrations from falling in healthy men. J Nutr. 2011 Apr 1;141(4):703-7. doi: 10.3945/jn.110.137323. Epub 2011 Feb 23.
PMID: 21346100BACKGROUNDPerakakis N, Kokkinos A, Angelidi AM, Tsilingiris D, Gavrieli A, Yannakoulia M, Tentolouris N, Mantzoros CS. Circulating levels of five proglucagon-derived peptides in response to intravenous or oral glucose or lipids and to a mixed-meal in subjects with normal weight, overweight, and obesity. Clin Nutr. 2022 Sep;41(9):1969-1976. doi: 10.1016/j.clnu.2022.07.001. Epub 2022 Jul 19.
PMID: 35961260DERIVEDGavrieli A, Fragopoulou E, Mantzoros CS, Yannakoulia M. Gender and body mass index modify the effect of increasing amounts of caffeinated coffee on postprandial glucose and insulin concentrations; a randomized, controlled, clinical trial. Metabolism. 2013 Aug;62(8):1099-106. doi: 10.1016/j.metabol.2013.02.003. Epub 2013 Mar 15.
PMID: 23498899DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mary Yannakoulia, PhD
Harokopio University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
December 16, 2011
First Posted
December 20, 2011
Study Start
January 1, 2011
Primary Completion
June 1, 2011
Study Completion
June 1, 2011
Last Updated
December 20, 2011
Record last verified: 2011-12